Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2015-11-04
Target enrollment:
Participant gender:
Summary
SPIL1033 resembles a gut hormone, which increases the insulin secretion, thus helps in
reducing blood glucose levels. The purpose of study is to establish safety and efficacy of
SPIL1033